TABLE 1.
Characteristics of patients with medulloblastoma in the training cohort and testing cohort.
Characteristic | Overall (n = 122) | Training cohort (n = 82) | Testing cohort (n = 30) | P-value |
Sex | 0.6983 | |||
Male | 86 (70.5%) | 64 (69.6%) | 22 (73.3%) | |
Female | 36 (29.5%) | 28 (30.4%) | 8 (26.7%) | |
Age (year)* | 11.57 ± 10.61 | 11.60 ± 11.05 | 11.46 ± 9.12 | 0.9028 |
Location | 0.6365 | |||
1 | 17 (13.9%) | 13 (14.1%) | 4 (13.3%) | |
2 | 7 (5.8%) | 4 (4.4%) | 3 (10.0%) | |
3 | 98 (80.3%) | 75 (81.5%) | 23 (76.7%) | |
Hydrocephalus | 0.8482 | |||
Absent | 51 (41.8%) | 38 (41.3%) | 13 (43.3%) | |
Present | 71 (58.2%) | 54 (58.7%) | 17 (56.7%) | |
Molecular subgroups | 0.8037 | |||
Wingless | 21 (17.2%) | 15 (16.3%) | 6 (20.0%) | |
Sonic hedgehog | 20 (16.4%) | 16 (17.4%) | 4 (13.3%) | |
Group 3 | 54 (44.3%) | 40 (43.5%) | 14 (46.7%) | |
Group 4 | 27 (22.1%) | 21 (22.8%) | 6 (20.0%) |
Data are numbers of patients, with percentages in parentheses. * Data are means ± SD. 1, cerebellar hemisphere; 2, cerebellar peduncle/cerebellopontine angle cistern; 3, midline vermian/fourth ventricle.